Alerts

Now Financial Businesses can provide their services to licensed cannabis businesses without penalty under California law.

Applicable drug manufacturers and group purchasing organizations that are subject to the reporting rules under the Open Payments System are reminded that March 31, 2021, is the final day to submit and attest to data for the June 2021 publication of Program Year 2020 data.

Considerations for businesses continuing remote work.

The subpoena issuance suggests that the Biden Administration will continue the US Government’s assertive approach to China.

What the new Congress could mean for federal cannabis reform.

Headlines that Matter for Companies and Executives in Regulated Industries

DOL announced last week that it would not enforce a final rule requiring fiduciaries subject to ERISA to evaluate investment opportunities based upon financial performance factors, rather than ESG metrics. 

With so much uncertainty, many brands are opting for a wait-and-see approach to social media advertising, though the approaches differ considerably from platform to platform.

Arent Fox’s International Group is launching a new podcast. “WorldSmart” will feature Group Co-Leaders Hunter Carter and Malcolm McNeil holding a fun and candid discussion on global issues, trends, and news surrounding the international arena. Each month will feature a new guest speaker.

Immediately at issue was Lilly and Company and Lilly USA’ refusal to sell covered outpatient drugs at the 340B Ceiling Price to contract pharmacies acting as agents for 340B Covered Entities. Several 340B Covered Entities had petition for a hearing by the ADR panel.

The California Consumer Privacy Act (CCPA) requires that the Attorney General establishes a recognizable and uniform opt-out logo or button to promote consumer awareness of the opportunity to opt-out of the sale of personal information.

Companies should be prepared to conduct additional due diligence for any transactions involving entities in the countries enumerated in this rule.

The American Rescue Plan of 2021 (the Rescue Plan) is a massive $1.9 trillion COVID-19 pandemic relief package that contains some key employment-related provisions.

We have seen biopharmaceutical companies around the world partnering to tackle COVID-19 in diagnostics, treatment development, vaccine development, and other relief efforts, including monetary and in-kind donations of lab equipment, instruments, and personal protective equipment (PPE).

Prop 65 Counsel: What To Know

A dispute over the use of the word “Inter” that has been ongoing between Major League Soccer (MLS) and Inter Milan is now the subject of settlement discussions, according to a March 2 filing MLS submitted to the US Patent and Trademark Office (USPTO).

Headlines that Matter for Companies and Executives in Regulated Industries

The American Rescue Plan Act of 2021, signed into law by President Biden on March 11, 2021, is a $1.9 trillion aid package that provides assistance to businesses and individuals experiencing financial hardship due to COVID-19.

With SEC claims on the rise and the recent Whistleblower amendments, FinTech businesses will be well-served by reviewing their compliance operations and consulting with counsel as needed to mitigate avoidable risk. 

The Employee Retention Tax Credit (ERTC) has been expanded and extended further, providing relief to small and large employers affected by COVID-19 business disruptions. As we approach the one-year anniversary of its original enactment, employers should take a fresh look at their eligibility for the

At $1.9 trillion, the American Rescue Plan Act of 2021, signed into law by President Biden on March 11, 2021, is the largest aid package passed by Congress since the start of the pandemic.

The United Kingdom’s Financial Conduct Authority announced the future cessation and loss of representativeness of worldwide LIBOR rates.

Students need to be aware of the current state of Student and Exchange Visitor Program (SEVP) guidance during the pandemic, various COVID-19-related travel bans, as well as the operating statuses of embassies and consulates around the world.

Non-compete agreements have recently come under attack across the country, both at the state and federal levels.

CBP is leveraging the EAPA to target various industries based on a suspicion of evading AD/CVD duties by aggressively scrutinizing imports potentially covered by an AD/CVD order.